I would agree in the absent of anything... something is an improvement. he seems to have an understanding of fundamentals. I'm concerned with his churn (hasn't stayed in a position long and when he has changed it's been to a different company). Though not under his leadership the last company he was with has shown a significant decrease in PPS. Likely to the point to threaten their NasDaq listing. We can all say and think what we want... only time will tell. Our owner and acting CEO has experience leading companies from birth to giants so I'll give him the benefit of the doubt. I'm just disappointed a more seasoned or vetted CFO was not selected. He is not the multi-billion dollar CFO we had hoped for or will need in what we hope is the near future. Granted... pre-revenue maybe that's the best we could do.
(1)
(1)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links